Triggered content release from optimized stealth thermosensitive liposomes using mild hyperthermia
Liposomes are potent nanocarriers to deliver chemotherapeutic drugs to tumors. However, the inefficient drug release hinders their application. Thermosensitive liposomes (TSL) can release drugs upon heat. This study aims to identify the optimum 1,2-distearoyl- sn-glycero-3-phosphoethanolamine- N-PEG...
Gespeichert in:
Veröffentlicht in: | Journal of controlled release 2010-04, Vol.143 (2), p.274-279 |
---|---|
Hauptverfasser: | , , , , , , , |
Format: | Artikel |
Sprache: | eng |
Schlagworte: | |
Online-Zugang: | Volltext |
Tags: |
Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!
|
Zusammenfassung: | Liposomes are potent nanocarriers to deliver chemotherapeutic drugs to tumors. However, the inefficient drug release hinders their application. Thermosensitive liposomes (TSL) can release drugs upon heat. This study aims to identify the optimum 1,2-distearoyl-
sn-glycero-3-phosphoethanolamine-
N-PEG
2000 (DSPE-PEG
2000) concentration in stealth TSL to improve content release efficiency under mild hyperthermia (HT). TSL were prepared with DSPE-PEG
2000 from 1 to 10
mol%, around 80
nm in size. Quenched carboxyfluorescein (CF) in aqueous phase represented encapsulated drugs.
In vitro temperature/time-dependent CF release and TSL stability in serum were quantified by fluorometry.
In vivo CF release in dorsal skin flap window chamber models implanted with human BLM melanoma was captured by confocal microscopy.
In vitro heat triggered CF release increased with increasing DSPE-PEG
2000 density. However, 6
mol% and higher DSPE-PEG
2000 caused CF leakage at physiological temperature. TSL with 5
mol% DSPE-PEG
2000 were stable at 37
°C, while released 60% CF in 1
min and almost 100% CF in 1
h at 42
°C.
In vivo optical intravital imaging showed immediate massive CF release above 41
°C. In conclusion, incorporation of 5
mol% DSPE-PEG
2000 optimized stealth TSL content release triggered by HT.
[Display omitted] |
---|---|
ISSN: | 0168-3659 1873-4995 |
DOI: | 10.1016/j.jconrel.2010.01.006 |